Crohn's Disease and Colitis Trial, Recruiting NCT07337902 Sponsor: University of North Carolina, Chapel Hill Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07337902
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 44 years old
  • You were assigned female at birth
  • You have been diagnosed with Crohn's Disease
  • Your Crohn's Disease is currently stable and under control, without the use of steroid medications
  • You experience painful periods (a condition you have reported yourself)
  • Your menstrual cycles happen regularly, every 23 to 35 days
  • You are using a reliable form of birth control or are not sexually active

Who may not be able to join:

  • You have been diagnosed with any of the following: endometriosis, adenomyosis, polycystic ovarian syndrome (PCOS), fibroids or polyps in the uterus, chronic pelvic inflammatory disease, or any other medical condition affecting the pelvic area
  • You have previously had pelvic surgery, including removal of the uterus (hysterectomy)
  • You are currently pregnant
  • You are planning to become pregnant during the study
  • You have been taking an oral contraceptive pill for less than 3 months, have recently changed your dose or switched to a different pill in the last 3 months, or plan to do so during the trial
  • You are taking hormone therapy (such as estrogen or progesterone) that is not part of a contraceptive
  • You have a known allergy or medical reason not to take ibuprofen or acetaminophen (paracetamol)
  • You are unable to complete online questionnaires, for example due to difficulty understanding them, or not having access to a smartphone or computer
  • You are not able to speak and read English

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 March 2026
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Proportion of Participants Who Express Interest in the Study Out of Those Contacted; Proportion of participants who enroll out of those who expressed interest in the study; Proportion of participants who meet the minimum adherence needed to contribute effectively to a subsequent study out of those randomized

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov